Cigna Corp. (CI) News
Filter CI News Items
CI News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CI News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest CI News From Around the Web
Below are the latest news stories about CIGNA GROUP that investors may wish to consider to help them evaluate CI as an investment opportunity.
The Cigna Group Foundation Supports Mental Health and Housing Stability for Veterans, Announcing First Round of Grant RecipientsThe Cigna Group Foundation announced today 22 recipients for the first year of its new grant program that aims to improve veteran mental health with a focus on housing stability. Through this initiative, The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), is allocating $9 million over the next three years as part of its continuing focus on veteran well-being. |
CVS successfully converts commercial pharmacy contracts to “cost plus” modelCVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging margins. |
Cigna Stock Plunges 18.7% in 3 Months: Should You Buy, Hold or Sell?Despite market challenges, CI's strong fundamentals and growth drivers make it worth holding for long-term investors looking to capitalize on future recovery opportunities. |
Cigna price target lowered to $390 from $420 at TruistTruist lowered the firm’s price target on Cigna (CI) to $390 from $420 and keeps a Buy rating on the shares as part of a broader research note previewing 2025 for Healthcare Services. The firm sees the outlook for the group as “mixed”, with bullish stance on the underlying demand drivers and overarching sector tailwinds that include demographics, value-based care, and core demand being offset by heightened concern around a likely more cost focused government backdrop. Selectivity is key and cash |
Investors in Cigna Group (NYSE:CI) have seen decent returns of 47% over the past five yearsThe Cigna Group ( NYSE:CI ) shareholders might be concerned after seeing the share price drop 19% in the last quarter... |
Healthcare Executives Bullish on 2025: But Why Are Stocks Slipping?Improving the consumer experience, engagement and trust is emerging as a top strategy for healthcare companies. |
The 7 biggest health insurance companies that control almost 75% of the marketOver the past few years the health insurance industry has experienced a series of major mergers and acquisitions, further consolidating power into the hands of a few dominant companies — leaving Americans with fewer options. |
PBMs have evaded lawmakers’ reform attempts so far. Could 2025 turn the tide?How regulators could hit PBMs from multiple sides in the coming year. |
Are The Cigna Group's (NYSE:CI) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?With its stock down 19% over the past three months, it is easy to disregard Cigna Group (NYSE:CI). It is possible that... |
Here's Why Cigna (CI) is a Strong Value StockWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |